Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizio Vitulo

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2020
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertensionMichele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, et al.
Pulmonary Circulation|August 26, 2022
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertensionSylvia M Nikkho, Manuel J Richter, Eric Shen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 23, 2016
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trialPatrizio Vitulo, Anna Stanziola, Marco Confalonieri, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
Giornale Italiano Di Cardiologia (2006)|February 27, 2024
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension]Marco Vatrano, Giovanna Manzi, Claudio Picariello, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Minerva Cardiology and Angiology|March 11, 2021
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosisCristiano Miotti, Andrea M D'Armini, Beatrice Scardovi, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Microorganisms|July 8, 2020
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern ItalyLorenzo Cavagna, Elena Seminari, Giovanni Zanframundo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 17, 2024
Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus/human herpesvirus-8 infections for early recognition and effective treatment of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome in solid organ transplant recipientsAlessandra Mularoni, Andrea Cona, Matteo Bulati, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2020
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertensionMichele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, et al.
Pulmonary Circulation|August 26, 2022
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertensionSylvia M Nikkho, Manuel J Richter, Eric Shen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 23, 2016
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trialPatrizio Vitulo, Anna Stanziola, Marco Confalonieri, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
Giornale Italiano Di Cardiologia (2006)|February 27, 2024
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension]Marco Vatrano, Giovanna Manzi, Claudio Picariello, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Minerva Cardiology and Angiology|March 11, 2021
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosisCristiano Miotti, Andrea M D'Armini, Beatrice Scardovi, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Microorganisms|July 8, 2020
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern ItalyLorenzo Cavagna, Elena Seminari, Giovanni Zanframundo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 17, 2024
Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus/human herpesvirus-8 infections for early recognition and effective treatment of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome in solid organ transplant recipientsAlessandra Mularoni, Andrea Cona, Matteo Bulati, et al.
Pageof 8